The number of methods to pre-screen and diagnose obstructive sleep apnea is very limited although it causes huge direct and indirect economic cost. In addition, the current methods to treat OSA are cumbersome and expensive.
Nukute has developed a novel, convenient and cost effective technology to pre-screen and assist in treatment of obstructive sleep apnea (OSA) – potentially serious sleep disorder in which breathing repeatedly stops and starts during sleep. To explore the feasibility of market entry to the U.S., Spinverse helped Nukute to apply for funding.
How we reached the goals
Spinverse strongly supported in project planning, proposal writing and evaluation of the quality of the proposal before submission.
Nukute has developed a cost-effective wireless system, based on microphone and accelerometers, equipped with a user-friendly mobile app.
The project aims to explore the feasibility of market entry to the U.S. in the pre-screening and treatment device markets.
Read our post on Nukute!